http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2394664-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_091948196f6e8cd318cea821e4222779
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2010-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d5e9a5764def9ab82d240fe79b6a7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990890d8fd52eb56e9c6f1b071ac8628
publicationDate 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2394664-A1
titleOfInvention Antipsychotic injectable depot composition
abstract The present invention is directed to a composition that can be used to deliver an antipsychotic drug such as risperidone as an injectable in-situ forming biodegradable implant for extended release providing therapeutic plasma levels from the first day. The composition is in the form of drug suspension on a biodegradable and biocompatible copolymer or copolymers solution using water miscible solvents that is administered in liquid form. Once the composition contacts the body fluids, the polymer matrix hardens retaining the drug, forming a solid or semisolid implant that releases the drug in a continuous manner. Therapeutic plasma levels of the drug can be achieved since the first day up to at least 14 days or more.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023046731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110420212-A
priorityDate 2010-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673767-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008287464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6331311-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3773919-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5688801-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4530840-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3636956-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4938763-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4523591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6803055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004247870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7118763-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005042294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008153611-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007041410-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4938763-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4389330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5620700-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128939139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129101897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128434470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073

Total number of triples: 50.